← Evidence map

ArticlePloS one2014

Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.

Jiang Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25340526